يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Immunoteràpia - Efectes secundaris"', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Nasca V, Corti F, Niger M Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy. Barretta F Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale dei Tumori, Milano, Italy. Lonardi S Department of Medical Oncology, Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy. Elez ME Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Ros J Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Journal for ImmunoTherapy of Cancer;11(1); http://dx.doi.org/10.1136/jitc-2022-005493Test; Nasca V, Barretta F, Corti F, Lonardi S, Niger M, Elez ME, et al. Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer. J Immunother Cancer. 2023 Jan 2;11(1):e005493.; https://hdl.handle.net/11351/9069Test; 000907632800006

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Robles-Alonso V Unitat d’Atenció Crohn-Colitis, Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Martínez-Valle F Unitat de Malalties Autoimmunes, Servei de Medicina Interna, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Borruel N Unitat d’Atenció Crohn-Colitis, Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Medicine;9; https://doi.org/10.3389/fmed.2022.906098Test; Robles-Alonso V, Martínez-Valle F, Borruel N. Co Treatment With Biologic Agents and Immunotherapy in the Setting of irAEs of Difficult Management. Front Med. 2022 Jun 30;9:90698.; https://hdl.handle.net/11351/8213Test; 000826727200001

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Majem M Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, c/Sant Antoni Maria Claret 167, 08025 Barcelona, Spain. Spanish Group for Cancer Immuno-Biotherapy, GÉTICA, Madrid, Spain. García-Martínez E Department of Medical Oncology and Hematology, Hospital Universitario Morales Meseguer, Murcia, Spain. Spanish Group for Cancer Immuno-Biotherapy, GÉTICA, Madrid, Spain. Martinez M Department of Medical Oncology, Hospital del Mar, Barcelona, Spain. Muñoz-Couselo E Servei de Medicina Oncològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Melanoma and Other Skin Tumors Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Rodriguez-Abreu D Department of Medical Oncology, C.H.U. Insular-Materno Infantil de Gran Canaria, Las Palmas, Spain. Spanish Group for Cancer Immuno-Biotherapy, GÉTICA, Madrid, Spain. Alvarez R Department of Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical and Translational Oncology;22; https://doi.org/10.1007/s12094-019-02273-xTest; Majem M, García-Martínez E, Martinez M, Muñoz-Couselo E, Rodriguez-Abreu D, Alvarez R, et al. SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019). Clin Transl Oncol. 2020 Feb;22:213–222.; https://hdl.handle.net/11351/6313Test; 000514525700006

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Draibe JB, Martinez-Valenzuela L, Fulladosa X Nephrology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain. García-Carro C, Agraz I, Bolufer M Grup de Recerca en Nefrologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Soler MJ Grup de Recerca en Nefrologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Red de Investigación Renal (REDINREN), Instituto Carlos III, FEDER, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical Kidney Journal;14(3); https://doi.org/10.1093/ckj/sfaa027Test; Draibe JB, García-Carro C, Martinez-Valenzuela L, Agraz I, Fulladosa X, Bolufer M, et al. Acute tubulointerstitial nephritis induced by checkpoint inhibitors versus classical acute tubulointerstitial nephritis: are they the same disease? Clin Kidney J. 2021 Mar;14(3):884–90.; https://hdl.handle.net/11351/6570Test; 000646249700019

  5. 5

    المساهمون: Institut Català de la Salut, [Robles-Alonso V] Unitat d’Atenció Crohn-Colitis, Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Martínez-Valle F] Unitat de Malalties Autoimmunes, Servei de Medicina Interna, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Borruel N] Unitat d’Atenció Crohn-Colitis, Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  6. 6

    المساهمون: Institut Català de la Salut, [Draibe JB, Martinez-Valenzuela L, Fulladosa X] Nephrology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain. [García-Carro C, Agraz I, Bolufer M] Grup de Recerca en Nefrologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Soler MJ] Grup de Recerca en Nefrologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Red de Investigación Renal (REDINREN), Instituto Carlos III, FEDER, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    Scientia
    Clinical Kidney Journal

    مصطلحات موضوعية: acute tubular nephritis, medicine.medical_specialty, enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::insuficiencia renal::lesión renal aguda [ENFERMEDADES], Urinary system, kidney biopsy, Kidney biopsy, 030232 urology & nephrology, Immunoteràpia - Efectes secundaris, Renal function, Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Nephritis::Nephritis, Interstitial [DISEASES], 030204 cardiovascular system & hematology, Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Gastroenterology, immune checkpoint inhibitors, Immune checkpoint inhibitors, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Acute tubular nephritis, Internal medicine, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological [CHEMICALS AND DRUGS], Other subheadings::Other subheadings::/adverse effects [Other subheadings], Medicine, steroid therapy, AcademicSubjects/MED00340, Acute tubulointerstitial nephritis, Adverse effect, Transplantation, Creatinine, medicine.diagnostic_test, business.industry, Steroid therapy, enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::nefritis::nefritis intersticial [ENFERMEDADES], Acute kidney injury, Original Articles, Ronyons - Malalties, medicine.disease, Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Acute Kidney Injury [DISEASES], acute kidney injury, chemistry, Nephrology, Renal biopsy, business, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica [COMPUESTOS QUÍMICOS Y DROGAS], Nephritis, hormones, hormone substitutes, and hormone antagonists

    وصف الملف: application/pdf

  7. 7

    المساهمون: Institut Català de la Salut, [Majem M] Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, c/Sant Antoni Maria Claret 167, 08025 Barcelona, Spain. Spanish Group for Cancer Immuno-Biotherapy, GÉTICA, Madrid, Spain. [García-Martínez E] Department of Medical Oncology and Hematology, Hospital Universitario Morales Meseguer, Murcia, Spain. Spanish Group for Cancer Immuno-Biotherapy, GÉTICA, Madrid, Spain. [Martinez M] Department of Medical Oncology, Hospital del Mar, Barcelona, Spain. [Muñoz-Couselo E] Servei de Medicina Oncològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Melanoma and Other Skin Tumors Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Rodriguez-Abreu D] Department of Medical Oncology, C.H.U. Insular-Materno Infantil de Gran Canaria, Las Palmas, Spain. Spanish Group for Cancer Immuno-Biotherapy, GÉTICA, Madrid, Spain. [Alvarez R] Department of Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: CLINICAL & TRANSLATIONAL ONCOLOGY
    r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
    instname
    Scientia
    Clinical & Translational Oncology
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Immune checkpoint inhibitors, Immunoteràpia - Efectes secundaris, administración de los servicios de salud::calidad de la atención sanitaria::garantía de calidad de la atención sanitaria::directrices como asunto::guías de práctica clínica como asunto [ATENCIÓN DE SALUD], Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores], Medical Oncology, neoplasias [ENFERMEDADES], Immune system, Antineoplastic Agents, Immunological, Health Services Administration::Quality of Health Care::Quality Assurance, Health Care::Guidelines as Topic::Practice Guidelines as Topic [HEALTH CARE], Intervention (counseling), Neoplasms, medicine, Other subheadings::Other subheadings::/adverse effects [Other subheadings], Humans, In patient, Intensive care medicine, Adverse effect, Societies, Medical, Clinical Trials as Topic, Toxicity, business.industry, Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Càncer - Tractament, terapéutica::terapia biológica::inmunomodulación::inmunoterapia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Disease Management, General Medicine, Immunotherapy, Guideline, Evidence-based medicine, Neoplasms [DISEASES], Oncology, Practice Guidelines as Topic, irAEs, Protocols clínics, business

    وصف الملف: application/pdf